These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 20691250)
1. Furanocoumarins-imperatorin inhibits myocardial hypertrophy both in vitro and in vivo. Zhang Y; Cao Y; Zhan Y; Duan H; He L Fitoterapia; 2010 Dec; 81(8):1188-95. PubMed ID: 20691250 [TBL] [Abstract][Full Text] [Related]
2. Imperatorin prevents cardiac hypertrophy and the transition to heart failure via NO-dependent mechanisms in mice. Zhang Y; Cao Y; Duan H; Wang H; He L Fitoterapia; 2012 Jan; 83(1):60-6. PubMed ID: 21983344 [TBL] [Abstract][Full Text] [Related]
3. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice. Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839 [TBL] [Abstract][Full Text] [Related]
4. Effect of sodium houttuyfonate on myocardial hypertrophy in mice and rats. Gao JP; Chen CX; Wang Y; Lü J; Gu WL J Pharm Pharmacol; 2009 May; 61(5):677-83. PubMed ID: 19406008 [TBL] [Abstract][Full Text] [Related]
5. Temporal characteristics of cardiomyocyte hypertrophy in the spontaneously hypertensive rat. Bell D; Kelso EJ; Argent CC; Lee GR; Allen AR; McDermott BJ Cardiovasc Pathol; 2004; 13(2):71-8. PubMed ID: 15033155 [TBL] [Abstract][Full Text] [Related]
6. [Changes of mitogen-activated protein kinase activity in cardiac tissues, Ang II and cardiac hypertrophy in spontaneously hypertensive rats]. He KL; Zheng QF; Mu SC; Li TC; Pang YZ; Tang CS Sheng Li Xue Bao; 1998 Oct; 50(5):539-42. PubMed ID: 11367750 [TBL] [Abstract][Full Text] [Related]
7. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes. Li H; Shi S; Sun YH; Zhao YJ; Li QF; Li HZ; Wang R; Xu CQ Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):312-8. PubMed ID: 18986329 [TBL] [Abstract][Full Text] [Related]
8. [The sarcoplasmic reticulum Ca2+ handling protein and left ventricular hypertrophy in SHR]. Zhu B; Zhang J; Liu N Zhonghua Yi Xue Za Zhi; 1999 Apr; 79(4):286-8. PubMed ID: 11601055 [TBL] [Abstract][Full Text] [Related]
9. Activation of adenosine A1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure-overload model. Liao Y; Takashima S; Asano Y; Asakura M; Ogai A; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Ogita H; Tomoike H; Hori M; Kitakaze M Circ Res; 2003 Oct; 93(8):759-66. PubMed ID: 12970111 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of ADP-ribosyl cyclase attenuates angiotensin II-induced cardiac hypertrophy. Gul R; Park JH; Kim SY; Jang KY; Chae JK; Ko JK; Kim UH Cardiovasc Res; 2009 Feb; 81(3):582-91. PubMed ID: 18719074 [TBL] [Abstract][Full Text] [Related]
11. Effects of KR-31378, a novel ATP-sensitive potassium channel activator, on hypertrophy of H9c2 cells and on cardiac dysfunction in rats with congestive heart failure. Hwang GS; Oh KS; Koo HN; Seo HW; You KH; Lee BH Eur J Pharmacol; 2006 Jul; 540(1-3):131-8. PubMed ID: 16729997 [TBL] [Abstract][Full Text] [Related]
12. [The role of nitric oxide in the angiotensin II-induced hypertrophy of cardiac myocytes]. Zhan CD; Wang TH; Pan JY Sheng Li Xue Bao; 1999 Dec; 51(6):660-6. PubMed ID: 11498936 [TBL] [Abstract][Full Text] [Related]
13. Antihypertension and anti-cardiovascular remodeling by phenylalanine in spontaneously hypertensive rats: effectiveness and mechanisms. Zhao G; Li Z; Gu T Chin Med J (Engl); 2001 Mar; 114(3):270-4. PubMed ID: 11780312 [TBL] [Abstract][Full Text] [Related]
15. Eriobotrya japonica ameliorates cardiac hypertrophy in H9c2 cardiomyoblast and in spontaneously hypertensive rats. Chiang JT; Badrealam KF; Shibu MA; Kuo CH; Huang CY; Chen BC; Lin YM; Viswanadha VP; Kuo WW; Huang CY Environ Toxicol; 2018 Nov; 33(11):1113-1122. PubMed ID: 29974613 [TBL] [Abstract][Full Text] [Related]
16. Transmural changes in size, contractile and electrical properties of SHR left ventricular myocytes during compensated hypertrophy. McCrossan ZA; Billeter R; White E Cardiovasc Res; 2004 Aug; 63(2):283-92. PubMed ID: 15249186 [TBL] [Abstract][Full Text] [Related]
17. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1. Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874 [TBL] [Abstract][Full Text] [Related]
18. G(alphaq)-protein carboxyl terminus imitation polypeptide GCIP-27 attenuates cardiac hypertrophy in vitro and in vivo. Zhang HG; Li XH; Zhou JZ; Liu Y; Jia Y; Yuan ZB Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1276-81. PubMed ID: 17973867 [TBL] [Abstract][Full Text] [Related]
19. Cardiac steroidogenesis and glucocorticoid in the development of cardiac hypertrophy during the progression to heart failure. Ohtani T; Mano T; Hikoso S; Sakata Y; Nishio M; Takeda Y; Otsu K; Miwa T; Masuyama T; Hori M; Yamamoto K J Hypertens; 2009 May; 27(5):1074-83. PubMed ID: 19349910 [TBL] [Abstract][Full Text] [Related]